In article of Rusudan Papaskiri "The role of costs in assessing the strategic position of the firm" is set up by for lack of expense on the specific market to reach the issue of leadership. Because users are very sensitive to the price of the goods, production-realization incurred expenses qualify size of price; hence companies systematically should be trying to reduce it. In an article one of the main ways are values of companies of improvement of the chain, its cleaning from overheads group, to replace expensive raw materials with cheap raw materials and many others.
No takes yet. Share an insight, caveat, or question.
Rusudan Papaskiri (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: